For the year ending 2025-12-31, BCAX has $430,994K in assets. $29,542K in debts. $96,685K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 96,685 | |||
| Prepaid expenses and other assets | 7,252 | |||
| Marketable securities | 318,116 | |||
| Total current assets | 422,053 | |||
| Property and equipment, net | 330 | |||
| Right of use asset operating lease | 1,701 | |||
| Other assets | 6,910 | |||
| Total assets | 430,994 | |||
| Accounts payable-Nonrelated Party | 5,515 | |||
| Accounts payable-Related Party | 2,278 | |||
| Accrued expenses and other current liabilities-Nonrelated Party | 18,898 | |||
| Accrued expenses and other current liabilities-Related Party | 1,141 | |||
| Operating lease liability current portion | 1,117 | |||
| Total current liabilities | 28,949 | |||
| Operating lease liability net of current portion | 593 | |||
| Total liabilities | 29,542 | |||
| Common stock, 0.0001 par value, 500,000,000 shares authorized 56,600,724 and 54,444,180 shares issued and 56,600,724 and 54,440,013 shares outstanding as of december31, 2025 and december31, 2024, respectively | 7 | |||
| Additional paid-in capital | 760,168 | |||
| Accumulated other comprehensive gain | 243 | |||
| Accumulated deficit | -358,966 | |||
| Total stockholders' equity | 401,452 | |||
| Total liabilities and stockholders equity | 430,994 | |||
Bicara Therapeutics Inc. (BCAX)
Bicara Therapeutics Inc. (BCAX)